feed,title,long_url,short_url
Benzinga,"Novo Nordisk Q4 Highlights: Clocks 25% Increase In Sales On Strong Diabetes and Obesity Treatment, Expects 13% - 19% Revenue Growth",https://benzinga.com/general/biotech/23/02/30662989/novo-nordisk-q4-highlights-clocks-25-increase-in-sales-on-strong-diabetes-and-obesity-treatment-e,https://da.gd/DXDRm
Benzinga,Why TransCode Therapeutics (RNAZ) Shares Are Trading Higher Today,https://benzinga.com/general/biotech/23/02/30664524/why-transcode-therapeutics-rnaz-shares-are-trading-higher-today,https://da.gd/M686j
